FELDMANN CYNTHIA L

CIK: 0001264554
Primary company: STERIS CORP (STE)

FELDMANN CYNTHIA L is a corporate insider at STERIS CORP (STE) filing SEC Form 4 transactions. 279 transactions across 9 companies, totaling $0 in purchases and $7,339,165 in sales. Source: SEC EDGAR.

AI Insider Summary

Cynthia L. Feldmann (CIK 0001264554) is an insider at Steris Corp (STE) whose most recent Form 4 recorded a transaction code M (market purchase) of 1,200 shares on June 12 2026 — a moderate open-market buy that falls within the routine-executive-activity tier rather than the material-signal tier at a $20-25B market-cap medical-device company. With disclosure across 9 companies and 25 recent transactions, Feldmann's profile is consistent with an active independent director or senior executive holding multiple board positions — a pattern whose Form 4 disclosures routinely include personal rebalancing, small market buys, and the occasional sell. The 1,200-share market purchase at STERIS (infection-prevention and surgical-products leader) is not block-sized and does not exhibit the timing characteristics (pre-announcement, full-position exit, single large discretionary buy) that would elevate it to a material-non-public-information tier. For smart-money insider trackers, Feldmann's June STE purchase should be filed as a routine-executive-buy reference: corroborating evidence (multiple same-code buys from different insiders in the same window) would be needed before this moves into the signal tier.

Steris Corp (STE) — medical device and infection-prevention company headquartered in Mentor Ohio. Products: (1) Sterilization systems (EtO, hydrogen peroxide, steam, V-PRO), (2) Surgical equipment (OR tables, lights, pendants), (3) Endoscopy and imaging, (4) Healthcare IT and service. Customers: hospitals, surgery centers, pharma/biotech manufacturing. STERIS benefits from (a) elective-surgery volume recovery post-COVID, (b) aging hospital infrastructure requiring sterilization upgrades, (c) pharmaceutical manufacturing expansion (sterile injectable capacity build-out).

Transaction (June 12 2026): code M = market purchase. 1,200 shares. Moderate size — not block. Consistent with director or executive personal purchase.

Analysis generated by 13F Insight from SEC Form 4 filing data. Methodology
Total Transactions
279
Total Buy Value
$0
Total Sell Value
$7.34M
Net Activity
$-7.34M
Last Transaction
Jun 2026
Companies
9

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

STERIS plc
STE
Type
Award
Shares
512
Price
-
Value
-
STERIS plc
STE
Type
Award
Shares
1,506
Price
$238.91
Value
$360K
Type
Exercise
Shares
1,200
Price
$43.95
Value
$53K
Type
Sale
Shares
100
Price
$240.40
Value
$24K
Type
Sale
Shares
1,100
Price
$239.19
Value
$263K
Type
Exercise
Shares
1,200
Price
$43.95
Value
$53K
Type
Award
Shares
802
Price
-
Value
-
STERIS plc
STE
Type
Exercise
Shares
3,495
Price
-
Value
-
STERIS plc
STE
Type
Sale
Shares
3,495
Price
$241.56
Value
$844K
STERIS plc
STE
Type
Exercise
Shares
3,495
Price
-
Value
-
STERIS plc
STE
Type
Award
Shares
487
Price
-
Value
-
STERIS plc
STE
Type
Award
Shares
1,407
Price
-
Value
-
Type
Award
Shares
625
Price
-
Value
-
Type
Exercise
Shares
2,756
Price
$38.61
Value
$106K
Type
Sale
Shares
207
Price
$231.51
Value
$48K
Type
Sale
Shares
2,549
Price
$230.66
Value
$588K
Type
Exercise
Shares
2,756
Price
$38.61
Value
$106K
Type
Award
Shares
2,032
Price
-
Value
-
Type
Sale
Shares
647
Price
$352.30
Value
$228K
STERIS plc
STE
Type
Award
Shares
494
Price
-
Value
-